Sweden may not be known for its vibrant medical sector, but healthcare innovation is definitely happening there. As the region’s largest life science partnering conference comes to a close this week, its organizers are calling attention to three young companies they say encompass the strength and innovation in their region.
Check out the companies given Nordic Stars Award at this year’s Nordic Life Science Days in Stockholm:
- Bone Index makes a pocket-sized medical device called Bindex that’s designed to diagnose osteoporosis in the primary care setting. The company says the device, which plugs into the USB port of a computer, uses non-harmful ultrasound and has been validated against the gold-standard for osteoporosis diagnosis. It’s CE marked and is awaiting FDA clearance.
- Immunotherapy company Lytix Biopharma is developing treatments for antibiotic-resistant infections and cancer. Its lead anti-cancer drug, LTX-315, has been tested in three Phase 1 cancer studies. LTX-109, its infection treatment, is in Phase 2 development.
- PledPharma also has two products in clinical development for colorectal cancer and myocardial infarction. In cancer, it’s focused on preventing side effects during chemotherapy. In myocardial infarction, the company hopes its drugs can limit damage to the heart from treatment with coronary angioplasty.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
[Image credit: Bone Index]
